KCTD3
BTB/POZ domain-containing protein KCTD3
Also known as: KCTD3_HUMAN, NY-REN-45
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y597
- Gene
- KCTD3
- Ensembl
- ENSG00000136636
- Chromosome
- 1
- Canonical length
- 815 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a member of the potassium channel tetramerization-domain containing (KCTD) protein family. Members of this protein family regulate the biophysical characteristics of ion channels. In mouse, this protein interacts with hyperpolarization-activated cyclic nucleotide-gated channel complex 3 and enhances its cell surface expression and current density. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
815 residues, UniProt reviewed canonical sequence.
>Q9Y597|KCTD3
1 MAGGHCGSFP AAAAGSGEIV QLNVGGTRFS TSRQTLMWIP DSFFSSLLSG RISTLRDETG
61 AIFIDRDPAA FAPILNFLRT KELDLRGVSI NVLRHEAEFY GITPLVRRLL LCEELERSSC
121 GSVLFHGYLP PPGIPSRKIN NTVRSADSRN GLNSTEGEAR GNGTQPVLSG TGEETVRLGF
181 PVDPRKVLIV AGHHNWIVAA YAHFAVCYRI KESSGWQQVF TSPYLDWTIE RVALNAKVVG
241 GPHGDKDKMV AVASESSIIL WSVQDGGSGS EIGVFSLGVP VDALFFIGNQ LVATSHTGKV
301 GVWNAVTQHW QVQDVVPITS YDTAGSFLLL GCNNGSIYYI DMQKFPLRMK DNDLLVTELY
361 HDPSNDAITA LSVYLTPKTS VSGNWIEIAY GTSSGAVRVI VQHPETVGSG PQLFQTFTVH
421 RSPVTKIMLS EKHLVSVCAD NNHVRTWTVT RFRGMISTQP GSTPLASFKI LSLEETESHG
481 SYSSGNDIGP FGERDDQQVF IQKVVPITNK LFVRLSSTGK RICEIQAVDC TTISSFTVRE
541 CEGSSRMGSR PRRYLFTGHT NGSIQMWDLT TAMDMVNKSE DKDVGGPTEE ELLKLLDQCD
601 LSTSRCATPN ISPATSVVQH SHLRESNSSL QLQHHDTTHE AATYGSMRPY RESPLLARAR
661 RTESFHSYRD FQTINLNRNV ERAVPENGNL GPIQAEVKGA TGECNISERK SPGVEIKSLR
721 ELDSGLEVHK IAEGFSESKK RSSEDENENK IEFRKKGGFE GGGFLGRKKV PYLASSPSTS
781 DGGTDSPGTA SPSPTKTTPS PRHKKSDSSG QEYSLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KCTD3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 73 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 73 nTPM
- liver: 67 nTPM
- breast: 63 nTPM
- small intestine: 47 nTPM
- duodenum: 43 nTPM
- retina: 37 nTPM
Single-cell type
- adrenal cortex cells: 333 nCPM
- esophageal apical cells: 220 nCPM
- breast lactating cells: 209 nCPM
- sertoli cells: 170 nCPM
- prostatic glandular cells: 162 nCPM
- prostatic hillock cells: 128 nCPM
Immune cell
- neutrophil: 0.7 nTPM
- basophil: 0.5 nTPM
- naive B-cell: 0.5 nTPM
- NK-cell: 0.5 nTPM
- plasmacytoid DC: 0.5 nTPM
- classical monocyte: 0.4 nTPM
Brain region
- cerebellum: 86 nTPM
- white matter: 81 nTPM
- medulla oblongata: 77 nTPM
- basal ganglia: 69 nTPM
- pons: 68 nTPM
- midbrain: 67 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KCTD3.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 113 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0.1
- gnomAD missense Z
- 2.76
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KCTD3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KCTD3 as an antibody target. Whether an autoantibody or antibody against KCTD3 could matter depends on whether native KCTD3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KCTD3 is annotated at the cell surface, where native KCTD3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KCTD3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...